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Abstract
Background: The burden of falciparum malaria is especially high in sub-Saharan Africa. Differences in pressure from
host immunity and antimalarial drugs lead to adaptive changes responsible for high level of genetic variations
within and between the parasite populations. Population-specific genetic studies to survey for genes under positive
or balancing selection resulting from drug pressure or host immunity will allow for refinement of interventions.
Methods: We performed a pooled sequencing (pool-seq) of the genomes of 100 Plasmodium falciparum isolates
from Nigeria. We explored allele-frequency based neutrality test (Tajima’s D) and integrated haplotype score (iHS)
to identify genes under selection.
Results: Fourteen shared iHS regions that had at least 2 SNPs with a score > 2.5 were identified. These regions code
for genes that were likely to have been under strong directional selection. Two of these genes were the chloroquine
resistance transporter (CRT) on chromosome 7 and the multidrug resistance 1 (MDR1) on chromosome 5. There was a
weak signature of selection in the dihydrofolate reductase (DHFR) gene on chromosome 4 and MDR5 genes on
chromosome 13, with only 2 and 3 SNPs respectively identified within the iHS window. We observed strong selection
pressure attributable to continued chloroquine and sulfadoxine-pyrimethamine use despite their official proscription
for the treatment of uncomplicated malaria. There was also a major selective sweep on chromosome 6 which had 32
SNPs within the shared iHS region. Tajima’s D of circumsporozoite protein (CSP), erythrocyte-binding antigen (EBA-175),
merozoite surface proteins - MSP3 and MSP7, merozoite surface protein duffy binding-like (MSPDBL2) and serine repeat
antigen (SERA-5) were 1.38, 1.29, 0.73, 0.84 and 0.21, respectively.
Conclusion: We have demonstrated the use of pool-seq to understand genomic patterns of selection and variability in
P. falciparum from Nigeria, which bears the highest burden of infections. This investigation identified known genomic
signatures of selection from drug pressure and host immunity. This is evidence that P. falciparum populations explore
common adaptive strategies that can be targeted for the development of new interventions.
Background
Malaria is a parasitic disease responsible for morbidity
in approximately 214 million people globally and an esti-
mated 438,000 deaths [1]. In the last two decades, there
have been significant decline in malaria prevalence due
to interventions with drug, long-lasting insecticidal nets
and other vectorial interventions. However, the disease
remains a significant public health problem in sub-
Saharan Africa (sSA) which harbours over 90% of the
worldwide burden [1]. The endemicity in sub-Saharan
Africa is heterogeneous, with some regions heading to-
wards elimination phase while hotspots of transmission
remain in others. This heterogeneity is imposed possibly
by differences in environments from rainfall, seasonality,
human and vector hosts as well as varied levels of inter-
ventions. One of the countries which remain heavily af-
fected is Nigeria. Nigeria bears the highest burden of
malaria (mostly from Plasmodium falciparum infections)
globally and interventions with drugs and anti-vector
tools suffer from logistic difficulties associated with the
economy and size of the country as well as extensive in-
fection movements [1]. This has been compounded by
antimalarial drug resistance, evasion of host immune
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response and lack of highly efficacious vaccines [2–4]. It
has been shown that high drug pressure and immunity
select for adaptive parasite strains that sustain transmis-
sion (2, 5). Thus, several P. falciparum genes encoding
drug or immune targets are under natural selection
and bear signatures of directional or balancing selec-
tion [5–7]. For a more effective management of inter-
ventions, it is important to determine patterns of
variation due to adaptation of the parasite to interven-
tions and host environments. While directional forces
cause adaptively important genetic variants of the
parasite to increase in frequency leading to high fix-
ation rates and the appearance of selective sweeps
around affected loci, balancing selection brings the par-
asite’s favoured alleles to an intermediate equilibrium,
where they are maintained as genetic polymorphisms. Al-
though population genomics of P. falciparum explored in
other West African populations have shown strong direc-
tional selection around known drug resistance genes and
signatures of balancing selection on multiple candidate
vaccine antigens [8–12], inferences of local adaptive
mechanisms require looking more representatively at indi-
vidual populations such as Nigeria.
Recent advances in next-generation genomics have
proved useful in individual sequencing of P. falciparum
in order to identify genes with polymorphic site fre-
quency spectra consistent with selection. However, such
technologies are still infeasible in resource-poor settings
where malaria is endemic and large data sets are re-
quired. High-throughput sequencing on samples pooled
from different individuals is a strategy that has been
adopted to characterize genetic variability in diploid
Drosophila at a small fraction of cost to detect single nu-
cleotide polymorphisms (SNPs) and their estimated fre-
quencies with a variance comparable with individual
sequencing [13]. To understand the genome-wide pat-
terns of selection in Nigeria, we sequenced pooled iso-
lates of P. falciparum and identified genes that are most
variable and potentially under strong directional and
balancing selection from antimalarial drug use and host
immunity.
Methods
Sample collection
Participants 2 years and above seeking care for uncom-
plicated malaria at three health centres - Aramoko-Ekiti
(AMK), Lekki (LEK) and Badagry (BDG) - in southwestern
Nigeria were recruited during the malaria season between
March and September, 2013 (Additional file 1: Figure S1),
[samples were collected as part of the Plasmodium Diver-
sity Network in Africa (PDNA) project]. All recruited mal-
aria cases had a temperature of > 37.5 °C on presentation
or history of fever in the previous 48 h, and a minimum of
5000 P. falciparum parasites/μl estimated by thick film
examination. Up to 5 ml of venous blood was collected
from each participant in sterile ethylene diamine tetracetic
acid (EDTA)-coated vacutainer tubes after which par-
ticipants were treated with artemether-lumefantrine ac-
cording to Nigeria’s treatment policy [14]. Collected
samples were transported in an ice-cold container to
the UK Medical Research Council Laboratories, The
Gambia for further analyses.
Parasite examination and pooled sequencing
Thick and thin blood films were prepared and exam-
ined under the microscope (Olympus CX21, Hamburg,
Germany) for confirmation of falciparum infections.
Plasmodium falciparum-infected blood was depleted of
white blood cells by size selection and hydrophoresis
using CF11 columns to reduce the presence of human
DNA [15]. Thick and thin blood films were prepared
before and after cellulose filtration to confirm complete
removal of leucocytes. Extraction of genomic DNA was
carried out using Qiagen Mini Kit (Qiagen, Hilden,
Germany). The extracted DNA samples were stored at
-20 °C for subsequent analysis. The quality as well as
quantity of each DNA sample was determined using
nanodrop (Thermo Fisher Scientific, MA, USA). Real-
time PCR was carried out to determine the quantity of
parasite DNA relative to human DNA contained in
each sample using the procedures described by Veron
et al. [16]. To further deplete human DNA extracted
with the parasite DNA, NEBNext Microbiome DNA
Enrichment Kit (New England Biolabs, MA, USA) was
used. Methylated human DNA was removed from the
DNA mixture by binding to the methyl-CpG binding
domain of human MBD2-Fc protein [17]. Concentra-
tions of individual parasite samples were normalized to
500,000 parasites/μl in a final volume of 920 μl of
pooled DNA. Enzymatic shearing, end-repair and
adapter-ligation leading to library preparation were car-
ried out using NEBNext library prep kit (New England
Biolabs, MA, USA). Library DNA was loaded on Ion
318™ chip (Thermo Fisher Scientific, MA, USA) and
run on the Ion Personal Genome Machine (Thermo
Fisher Scientific, MA, USA).
Data processing: alignment, variant calling and quality
filtering
Reads generated were aligned to P. falciparum 3D7
genome using mapping and assembly with quality
(MAQ) tools. We excluded reads of poor mapping
quality, and derived a list of SNPs [and small insertions
and deletions (indels)] based on uniquely mapping
reads and acceptable levels of coverage (minimum 10,
maximum 2000). In addition, we applied a filter to rule
out error-prone variant calls, based on a threshold of Q20.
Allele frequencies in the population were determined for
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all SNPs, by analyzing all genotyped samples. Non-
reference (variant) allele frequency (NRAF) was computed
as the proportion of genotyped samples whose allele was
not the reference allele. The reading frame and exon
boundaries were determined from the PlasmoDB 13.0 an-
notation of the 3D7 genome (www.plasmodb.org).
Identifying genes under balancing and directional
selections
The allele frequency-based neutrality test, Tajima’s D
[18], integrated haplotype score [19], and the ratio of
nonsynonymous and synonymous polymorphisms (πN/πS)
were applied to identify genes under selection. DnaSP 5.1
[20] was used to perform calculation of Tajima’s D ratios.
Evidence of recent directional selection was obtained from
the standardised haplotype score using WHAMM [19].
Extreme positive iHS scores (> 2.5) suggested selective
sweeps along the ancestral allele signaling strong direc-
tional selection around that site.
Results
High quality sequence data was obtained from genomic
DNA pooled from 100 clinical isolates of P. falciparum.
Genome-wide short-read sequences were generated
yielding a median short sequence read length of 182 bp.
Alignment to P. falciparum 3D7 reference genome indi-
cated an average genome-wide coverage depth of 5.7×
(Table 1). The sequencing technology yielded 488 mil-
lion bases and total usable reads of 3,090,240. Variant
calls were made at 56,784 polymorphic sites and 13,784
SNPs were identified after quality filtering. There was
> 65% more read coverage in the genic regions than in
the intergenic regions. Five thousand one hundred and
twenty-two genes had at least 3 SNPs and were consid-
ered informative for frequency-based analyses. In all,
3122 genes were analysed across the 14 chromosomes
of the parasite after excluding genes in the sub-
telomeric regions (var, rifin and stevor genes). Each
SNP was classified as synonymous or nonsynonymous
according to whether an amino acid change occurred
when substituting the reference allele with the non-
reference allele at that SNP in the 3D7 reference gen-
ome sequence, without any other changes. Comparison
between nonsynonymous and synonymous SNPs for
some known target genes of antimalarial drugs and im-
munity is presented in Fig. 1.
Evidence of positive directional selection
Standardised integrated haplotype score (iHS) was used
to examine evidence of recent directional selection.
Fourteen shared iHS regions that had at least 2 SNPs
with a score > 2.5 were identified (Table 2). Two of such
genes were chloroquine resistance transporter (CRT) on
chromosome 7 and multidrug resistance 1 (MDR1) on
chromosome 5. There was a weak signature of selection
in dihydrofolate reductase (DHFR) in chromosome 4
and MDR5 genes on chromosome 13 with only 2 and 3
SNPs respectively identified within the iHS window
(Table 3). However, there was no evidence of recent dir-
ectional selection in dihydropteroate synthase (DHPS)
gene on chromosome 8. There was also a major selective
sweep on chromosome 6 which had 32 SNPs within the
shared iHS region. However, the specific loci targeted by
the selective sweep were unknown.
Identifying signatures of balancing selection
Tajima’s D values were mostly negative (Additional file 2:
Table S1), with a mean value of -0.86. One hundred and
twelve genes (3.59%) had positive Tajima’s D values
(Fig. 2). Six genes that have been previously associated
with selection from acquired immunity had significantly
high Tajima’s D values (Table 4).
Discussion
This investigation adopted pooled DNA sequencing to
understand genome-wide patterns of selection and gen-
etic variability that had only been previously achievable
through individual sequencing [8, 12]. Regions of the
genome under recent positive and balancing selections,
representing signatures of adaptation to drug pressure
and host immunity, were identified. Earlier reports
showed no significant variance or population sub-
structuring in the study areas [21], eliminating the possi-
bility of false-positive results for signals of selection
owing to population structure.
Table 1 Summary of sequence mapping to the reference P.
falciparum genome
Alignment summary Mapping characteristics
Length of non-gap regions covered
by reads
13,226,305
Length of 24 bp unique regions of
the reference
264,683
Reference nucleotide composition A: 37.87%, C: 13.35%,
G: 14.62%, T: 34.16%
Reads nucleotide composition A: 36.07%, C: 15.71%,
G: 17.71%, T: 30.51%
Average depth across all non-gap
regions
0.691
Average depth across 24 bp
unique regions
0.514
Number of reference sequences 132,994
Length of reference sequences
excluding gaps
53,277,940
Length of gaps in the reference
sequences
1,299,037
Average coverage depth of
reference sequence
5.7×
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Drug pressure is a powerful selective force in natural
parasite populations. Removal of drug pressure exposes
resistant parasites to increased competition leading to a
decline in the frequency of resistance conferring selection
[22], as reported in Malawi where after just a decade of
non-use, chloroquine (CQ) cleared 100% of asymptomatic
P. falciparum infections [23]. Similarly, the prevalence of
CQ-resistant parasites in coastal Tanzania decreased after
only two and a half years of CQ withdrawal [24]. However,
in keeping with the observation of high distribution of
CQ-resistant parasites in western Kenya after a period of
drug withdrawal [25], the results of the present study
showed that the population of resistant parasites in the
Nigerian region studied did not reduce significantly after
years of CQ withdrawal. Instead, high extended haplotype
scores (iHS) were found for SNPs around chloroquine
resistant transporter (CRT) and multidrug resistance
(MDR1) genes. These observations are consistent with
Fig. 1 Distribution of synonymous and nonsynonymous SNPs among known gene targets of drug and immunity. Abbreviations: crt, chloroquine
resistant transporter; mdr, multidrug resistant transporter; dhfr, dihydrofolate reductase; dhps, dihydropteroate synthase; gdv, gametocyte
development; msp, merozoite surface protein; ubp1, deubiquitinating enzyme gene 1; lsa, liver stage antigen
Table 2 Windows of directional selection for genomic regions with shared iHS score 2.5
Chromosome Window Region (kb) Number of SNPs with iHS > 2.5 ID of genes within region
Start Stop
1 163 184 21 4 PF3D7_0103600 - PF3D7_0104200
2 302 515 213 1 PF3D7_0210900 - PF3D7_0213600
4 407 585 178 2 PF3D7_0409600 - PF3D7_0413300
5 822 1007 185 12 PF3D7_0519800 - PF3D7_0524200
6a 1039 1297 258 32 PF3D7_0625100 - PF3D7_0630600
7 238 249 11 4 PF3D7_0704550 - PF3D7_0704900
9 1060 1220 160 15 PF3D7_0929320 - PF3D7_0930500
10 1210 1557 347 10 PF3D7_1029500 - PF3D7_103880
11 1190 1310 200 8 PF3D7_1132920 - PF3D7_1133600
12 1451 1880 429 6 PF3D7_1234900 - PF3D7_1248500
13 303 358 55 3 PF3D7_1306470 –PF33D7_130790
13 2410 2520 110 3 PF3D7_1306470 - PF3D7_1307900
14 1910 1932 22 2 PF37_1407000 - PF3D7_1447900
aSelective sweep on chromosome 6 with 32 SNPs within the shared iHS region
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positive selection from long periods of chloroquine use
leading to depletion of chloroquine-susceptible parasites
[14]. Strong directional selection in these genes essentially
suggests that the re-introduction of the drug for malaria
treatment cannot be considered yet as drug resistant
strains still predominate the population. This is contrary
to previous observations which showed complete [23] or
partial [24] reversal of P. falciparum populations to
chloroquine susceptibility after a period of drug with-
drawal. In populations where malaria is endemic, trans-
mission is high, and acquired immunity is extensive,
asymptomatic adults, who rarely become ill and who
generally do not receive therapy, may provide a favorable
environment for susceptible parasites to persist in the
population. Malaria intervention efforts in Nigeria might
have resulted in lower transmission and less acquired im-
munity, shrinking refugia and allowing resistant alleles to
become fully fixed in the population, as was observed in
South America [26] and Southeast Asia [27].
There was no strong evidence of selection associated
with dihydrofolate reductase (DHFR) and dihydroptero-
ate synthase (DHPS), the two major genes targeted by
sulfadoxine-pyrimethamine (sulfadox). This supports re-
ports that the drug is still considerably effective for mal-
aria treatment [28]. Thus, its use as Intermittent
Preventive Treatment (IPT) of pregnant women remains
effective. However, the detection of weak selection on
DHFR gene implies selection acting in the drug resist-
ance locus as sulfadox is still widely available from the
informal pharmaceutical sector. There was also a major
selective sweep on chromosome 6 supporting previous
reports from Senegal [29] and The Gambia [9]. This is
the first evidence of the Chromsome 6 sweep beyond
the populations of Senegal and The Gambia which are
geographically linked. It therefore could be marking a
common selective event in the history of P. falciparum
in West Africa. However, further investigation is needed
to understand the origin and mechanisms of selection in
the chromosome region.
Against a genomic background in which most genes
had negative values of Tajima’s D, this study, in agree-
ment with observations in Senegal [12] and The Gambia
[8], has identified six genes to be under strong balancing
selection. These are some of the antigens that had been
previously proposed as vaccine candidates [8, 9]. How-
ever, not all genes with high positive values of Tajima’s D
are under the effect of balancing selection as demo-
graphic events such population contraction could also
lead to values greater than zero. Thus, the parasite sur-
face genes identified to be under balancing selection
may require further validation for selection from im-
munity or diversity of human erythrocyte receptors.
Immunological analyses of the allelic protein products of
these identified genes should be prioritized.
Table 3 Distribution of SNPs in some target genes of
antimalarial drugs and immunity
Gene Name Chromosome Position Number of SNPs
UBP1 1 190,269–210,230 4
LSA3 2 796,752–801,568 6
PFDHR 4 748,088–749,914 13
PFMDR1 5 957,890–962,149 8
PFCRT 7 403,222–406,317 5
PFDHPS 8 548,200–550,616 7
MSP1 9 1,201,812–1,206,974 6
GDV1 9 1,377,953–1,379,752 4
MSP3 10 1,404,195–1,405,259 5
LSA1 10 1,436,316–1,439,804 5
PFMDR5 13 1,598,401–1,601,178 10
Abbreviations: UBP1 ubiquitinating emzyme gene, CRT chloroquine resistant
transporter, MDR multidrug resistant transporter, DHFR dihydrofolate
reductase, DHPS dihydropteroate synthase, GDV gametocyte development,
MSP merozoite surface protein, LSA liver stage antigen
Fig. 2 Frequency distribution of Tajima’s D values for genic loci as
annotated in Plasmodium falciparum 3D7 v3 genome
Table 4 Genes showing high values of Tajima’s D
Gene ID Chromosome
number
Frequency of polymorphism
π × 10-3
Tajima’s D
MSPDBL2 10 27.9 2.58
CSP 3 20.6 1.38
EBA-175 7 17.2 1.29
MSP7 13 13.5 0.84
MSP3 10 23.8 0.73
SERA5 2 24.1 0.21
Abbreviations: MSPDBL2 merozoite surface protein duffy binding-like, CSP
circumsporozoite protein, EBA-175 erythrocyte-binding antigen, MSP merozoite
Surface Protein, EBA erythrocyte-binding antigen, SERA serine repeat antigen
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While pool-seq has been shown here to be a useful ap-
proach in population genomics of P. falciparum, it is
worthy of note that haplotype information may be
traded off under multiplexed sequencing. Although this
may be a necessary price for a cost-effective and accur-
ate characterization of SNP frequencies, it should not be
considered insignificant. Also, loss of resolution on
haplotype structure makes it difficult to separate demo-
graphic from complete selective events as patterns of
linkage disequilibrium (LD) cannot be resolved [12].
Futher application of this approach on P. falciparum
evolutionary analyses will benefit from a more detailed
comparison of allele frequency spectrum obtained with
that from individual sequencing.
Conclusion
We have demonstrated the use of pooled DNA se-
quencing to understand genome-wide patterns of se-
lection of P. falciparum previously achievable through
individual sequencing, identifying regions of the para-
site genome under the influence of drug and host
immune selection.
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